Skip to main content

October 2015

 

 

academics

 

Clinical research courses

Short and high intensity exercise can reduce an adolescent's risk of developing a heart condition, revealed a new study by researcher Alan Barker and his University of Exeter team. The researchers observed that performing eight to ten minutes of high intensity interval exercise thrice a week can improve important markers of cardiovascular health. The study is published in the Journal American Journal of Physiology - Heart and Circulatory Physiology.

The world's largest catalogue of genomic differences among humans, has been created by an international team of scientists. This catalogue would provide researchers with powerful clues to help them establish why some people are susceptible to various diseases. The findings were detailed in two studies that appeared online in the Nature.

A new study from the University of California, Berkeley has found an association between sleep and body mass index. Teenagers and adults who go to bed late on weeknights are more likely to gain weight than their peers who hit the bed earlier.  Moreover, exercise, screen time, and the number of hours they slept did not mitigate this BMI increase, according to the study published in the October issue of the journal, Sleep.

Job as PROCUREMENT ASSISTANT (5 Opening) in HLL Lifecare | B.Pharm, D.Pharm, B.Sc, M.Sc

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post: PROCUREMENT ASSISTANT

Application are invited for M.Pharm as Junior Research Fellow/ Senior Research Fellow/ Research Associate in Mizoram University

Applications are invited from eligible candidates for Junior Research Fellow (JRF)/ Senior Research Fellow (SRF)/ Research Associate (RA) for CSIR, New Delhi funded Major Research Project on ‘Characterization, Documentation and Bio prospection of Lichens from Murlen National Park, Mizoram’. Duration of the project is for two years (2015-2017).

Post: Junior Research Fellow (JRF)/ Senior Research Fellow (SRF)/ Research Associate (RA)

Walk in for Pharmacist in NRHM, Rajkot

Walk in interview for post of Pharmacist on temporary basis on eleven months contractual period under NRHM District Health Society.

Post: Pharmacist

Required for Pharmacovigilance Manager in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Pharmacovigilance Manager

Opening for Executive - Manufacturing Compliance Services in Mylan

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 16,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and custofmer service.

Post: Executive - Manufacturing Compliance Services - Unit-2 - 15002724

SEARCHED FOR CANCER CURE, FOUND IT EVERYWHERE !

ABOUT AUTHOR:
Vishwas B. Chawan
Consultant at Clinical Diagnostic Centre,
Mumbai, Maharashtra
vishwaschavan2003@yahoo.co.in

Cancer is called “Emperor of All Maladies.” Finding cure for cancer is one of the most important goal of medical research. Cancer is among the leading causes of morbidity and mortality worldwide. Globally, in the year 2012, cancer affected 14 million new people and 8.2 million people died from cancer or cancer-related complications[1]. Current cancer therapies are costly and have many side effects. Additional problems are development of resistance to treatment and recurrence of cancer even after initial successful treatment.